RecruitingNot Applicable

Sustaining Home Heart Failure Palliative Care in Rural Appalachia

United States208 participantsStarted 2025-04-01

Plain-language summary

The aim of this mixed methods randomized controlled trial is to test the integrated nurse-led intervention bundle for family home care management of end-stage heart failure and palliative care in rural Appalachia. This intervention bundle is designed to address rural disparities in access to health care, with the help of the faith-based nurses and local volunteer visiting neighbors.

Who can participate

Age range45 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients' age between 50 to 80 years with advanced HF (NYHA III or IV), diagnosed by physician
✓. Caregivers' age between 45 to 80 years.
✓. Alert and consent to participate
✓. Able to read and understand English

Exclusion criteria

✕. Already received or are on a waiting list for a heart transplant or left ventricular assist device (LVAD)
✕. Diagnosed with a terminal illness or dementia, such as Alzheimer's disease

What they're measuring

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: Baseline

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: 3 Month Follow up

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: 6 Month Follow up

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: 9 Month Follow up

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: 12 Month Follow Up

Patient--World Health Organization Quality of life Questionnaire

Timeframe: Baseline

Patient--World Health Organization Quality of life Questionnaire

Timeframe: 3 Month Follow up

Patient--World Health Organization Quality of life Questionnaire

Timeframe: 6 Month Follow up

Trial details

NCT IDNCT06791850

SponsorWest Virginia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-04-01

Contact for this trial

Ubolrat Piamjariyakul

304.293.6729 ubolrat.piamjariyakul@hsc.wvu.edu

View on ClinicalTrials.gov More Heart Failure NYHA Class III trials

Plain-language summary

Who can participate

Age range45 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patients' age between 50 to 80 years with advanced HF (NYHA III or IV), diagnosed by physician
✓. Caregivers' age between 45 to 80 years.
✓. Alert and consent to participate
✓. Able to read and understand English

Exclusion criteria

✕. Already received or are on a waiting list for a heart transplant or left ventricular assist device (LVAD)
✕. Diagnosed with a terminal illness or dementia, such as Alzheimer's disease

What they're measuring

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: Baseline

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: 3 Month Follow up

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: 6 Month Follow up

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: 9 Month Follow up

Patient's Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

Timeframe: 12 Month Follow Up

Patient--World Health Organization Quality of life Questionnaire

Timeframe: Baseline

Patient--World Health Organization Quality of life Questionnaire

Timeframe: 3 Month Follow up

Patient--World Health Organization Quality of life Questionnaire

Timeframe: 6 Month Follow up